Fundraising FoxBallast Point Ventures — 2017 Investments
2 investments dated 2017 · listed companies and verified rows first · show all
YPrime provides a clinical trial technology platform with patient engagement features (eConsent and eCOA) designed to accelerate trial timelines, improve data quality, and enhance participant experience for pharmaceutical companies, biotechs, and contract research organizations.
BiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaSMalvern, US
Jaime Cook(Executive Officer, Director)inShawn Blackburn(Executive Officer, Director)in
BoardMatthew Rice(Director)inElizabeth Tallett(Director)Richard Gastineau(Director)Paul Blake(Director)
Board seatSean Barkman· per SEC Form D
Co-investorsFlexpoint FordGray VenturesTopmark Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.